Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-050690

Options or other derivatives

  • Director acquired 16,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Baynes Roy D. Director 2018-09-11 Grant or award · Stock Option (Right to Buy) +16,500 16,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…